LeMaitre Vascular Company Profile (NASDAQ:LMAT)

About LeMaitre Vascular

LeMaitre Vascular logoLeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: LMAT
  • CUSIP:
Key Metrics:
  • Previous Close: $20.36
  • 50 Day Moving Average: $18.98
  • 200 Day Moving Average: $16.06
  • 52-Week Range: $11.80 - $22.50
  • Trailing P/E Ratio: 40.88
  • Foreward P/E Ratio: 32.32
  • P/E Growth: 2.49
  • Market Cap: $375.93M
  • Outstanding Shares: 18,464,000
  • Beta: 0.51
Profitability:
  • Net Margins: 11.43%
  • Return on Equity: 11.90%
  • Return on Assets: 10.25%
Debt:
  • Current Ratio: 6.16%
  • Quick Ratio: 4.49%
Additional Links:
Companies Related to LeMaitre Vascular:

Analyst Ratings

Consensus Ratings for LeMaitre Vascular (NASDAQ:LMAT) (?)
Ratings Breakdown: 1 Hold Rating, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $19.56 (3.92% downside)

Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)
Show:
DateFirmActionRatingPrice TargetDetails
9/22/2016SidotiDowngradeBuy -> Neutral$23.00View Rating Details
9/6/2016Canaccord GenuityReiterated RatingBuy$21.00View Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$17.50 -> $20.00View Rating Details
7/28/2016Barrington ResearchBoost Price TargetOutperform$18.50 -> $20.00View Rating Details
5/3/2016Roth CapitalBoost Price TargetBuy$18.00 -> $18.50View Rating Details
12/7/2015Dougherty & CoBoost Price TargetBuy$16.00 -> $19.00View Rating Details
12/4/2015Benchmark Co.Boost Price Target$15.00 -> $18.00View Rating Details
12/4/2015Stifel NicolausBoost Price TargetBuy$14.00 -> $17.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for LeMaitre Vascular (NASDAQ:LMAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016        
7/27/2016Q2$0.11$0.14$21.59 million$22.40 millionViewListenView Earnings Details
5/2/2016Q1$0.10$0.11ViewListenView Earnings Details
2/24/2016Q415$0.09$0.13$20.10 million$20.50 millionViewListenView Earnings Details
10/27/2015Q3$0.08$0.11ViewListenView Earnings Details
7/28/2015Q2$0.07$0.10ViewListenView Earnings Details
4/28/2015Q115$0.05$0.08$17.76 million$18.90 millionViewListenView Earnings Details
2/25/2015Q314$0.07$0.11$18.90 million$18.70 millionViewListenView Earnings Details
10/28/2014Q3$0.06$0.05ViewListenView Earnings Details
7/29/2014Q214$0.05$0.08$17.50 million$18.20 millionViewListenView Earnings Details
4/29/2014Q1$0.02$0.01ViewListenView Earnings Details
2/25/2014Q4$0.05$0.05ViewListenView Earnings Details
10/29/2013Q313$0.04$0.05$15.22 million$15.30 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for LeMaitre Vascular (NASDAQ:LMAT)
Current Year EPS Consensus Estimate: $0.55 EPS
Next Year EPS Consensus Estimate: $0.63 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.09$0.10$0.10
Q2 20162$0.11$0.11$0.11
Q3 20162$0.15$0.16$0.16
Q4 20162$0.15$0.15$0.15
Q1 20172$0.13$0.15$0.14
Q2 20172$0.16$0.16$0.16
Q3 20172$0.15$0.16$0.16
Q4 20172$0.18$0.18$0.18
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for LeMaitre Vascular (NASDAQ:LMAT)
Annual Dividend:$0.18
Dividend Yield:0.88%
Payout Ratio:36.73% (Based on Trailing 12 Months of Earnings)
32.73% (Based on Current Year Consensus EPS Estimate)
28.57% (Based on Next Year Consensus EPS Estimate)

Dividend History for LeMaitre Vascular (NASDAQ:LMAT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/29/2016quarterly$0.051.05%8/18/20168/22/20169/6/2016
5/4/2016quarterly$0.051.12%5/23/20165/25/20166/8/2016
2/25/2016quarterly$0.051.19%3/17/20163/21/20164/4/2016
10/29/2015quarterly$0.041.11%11/18/201511/20/201512/4/2015
7/29/2015quarterly$0.041.25%8/18/20158/20/20159/3/2015
4/29/2015quarterly$0.041.85%5/20/20155/22/20156/5/2015
2/26/2015quarterly$0.042.03%3/18/20153/20/20154/3/2015
10/28/2014quarterly$0.041.93%11/18/201411/20/201412/4/2014
7/31/2014quarterly$0.041.73%8/19/20148/21/20149/4/2014
4/30/2014quarterly$0.041.71%5/20/20145/22/20146/5/2014
2/26/2014quarterly$0.041.75%3/18/20143/20/20144/3/2014
10/31/2013quarterly$0.031.49%11/18/201311/20/201312/4/2013
7/30/2013quarterly$0.031.73%8/19/20138/21/20139/4/2013
5/2/2013quarterly$0.031.98%5/20/20135/22/20136/5/2013
2/27/2013quarterly$0.031.92%3/18/20133/20/20134/3/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for LeMaitre Vascular (NASDAQ:LMAT)
Insider Ownership Percentage: 28.90%
Institutional Ownership Percentage: 59.88%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/16/2016David B RobertsInsiderSell6,452$21.05$135,814.60View SEC Filing  
9/15/2016David B RobertsInsiderSell33,548$20.41$684,714.68View SEC Filing  
9/8/2016George W LemaitreChairmanSell30,000$20.48$614,400.00View SEC Filing  
9/7/2016David B RobertsInsiderSell20,000$20.07$401,400.00View SEC Filing  
9/2/2016George W LemaitreChairmanSell60,037$18.30$1,098,677.10View SEC Filing  
8/30/2016Peter R GebauerInsiderSell3,431$18.20$62,444.20View SEC Filing  
8/29/2016Peter R GebauerInsiderSell26,815$17.78$476,770.70View SEC Filing  
8/24/2016David B RobertsInsiderSell10,000$17.35$173,500.00View SEC Filing  
8/24/2016George W LemaitreCEOSell6,800$17.49$118,932.00View SEC Filing  
8/23/2016George W LemaitreCEOSell19,664$17.43$342,743.52View SEC Filing  
8/22/2016George W LemaitreCEOSell8,927$17.39$155,240.53View SEC Filing  
8/19/2016Cornelia W LemaitreDirectorSell5,000$17.15$85,750.00View SEC Filing  
8/18/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016George W LemaitreChairmanSell15,896$17.53$278,656.88View SEC Filing  
8/9/2016George W LemaitreChairmanSell5,460$17.41$95,058.60View SEC Filing  
8/9/2016Lawrence J JasinskiDirectorSell7,500$17.60$132,000.00View SEC Filing  
8/5/2016David B RobertsInsiderSell10,000$17.63$176,300.00View SEC Filing  
8/4/2016George W LemaitreChairmanSell4,540$17.65$80,131.00View SEC Filing  
7/28/2016Peter R GebauerInsiderSell30,000$16.47$494,100.00View SEC Filing  
6/8/2016George W LemaitreCEOSell19,189$15.01$288,026.89View SEC Filing  
6/7/2016George W LemaitreCEOSell9,100$15.02$136,682.00View SEC Filing  
6/6/2016George W LemaitreCEOSell900$15.06$13,554.00View SEC Filing  
6/6/2016Peter R GebauerInsiderSell6,310$14.96$94,397.60View SEC Filing  
6/3/2016Lawrence J JasinskiDirectorSell4,924$14.99$73,810.76View SEC Filing  
6/3/2016Trent G KamkeInsiderSell2,510$15.00$37,650.00View SEC Filing  
5/25/2016Lawrence J JasinskiDirectorSell6,326$15.30$96,787.80View SEC Filing  
5/25/2016Trent G KamkeInsiderSell1,524$15.25$23,241.00View SEC Filing  
5/23/2016Trent G KamkeInsiderSell16,465$15.02$247,304.30View SEC Filing  
5/18/2016George W LemaitreCEOSell2,944$15.23$44,837.12View SEC Filing  
5/17/2016Trent G KamkeInsiderSell2,400$15.51$37,224.00View SEC Filing  
5/16/2016George W LemaitreCEOSell1,740$15.49$26,952.60View SEC Filing  
5/13/2016George W LemaitreCEOSell7,451$15.45$115,117.95View SEC Filing  
5/9/2016George W LemaitreCEOSell110,189$16.17$1,781,756.13View SEC Filing  
5/6/2016David B RobertsDirectorSell17,064$15.89$271,146.96View SEC Filing  
5/5/2016Trent G KamkeInsiderSell3,327$16.10$53,564.70View SEC Filing  
4/18/2016David B RobertsDirectorSell1,766$16.10$28,432.60View SEC Filing  
4/4/2016David B RobertsDirectorSell17,444$15.99$278,929.56View SEC Filing  
2/25/2016David B RobertsDirectorSell2,690$15.91$42,797.90View SEC Filing  
1/14/2016David B. RobertsDirectorSell12,867$15.85$203,941.95View SEC Filing  
1/11/2016David B RobertsDirectorSell27,490$15.68$431,043.20View SEC Filing  
1/8/2016David B RobertsDirectorSell2,743$15.51$42,543.93View SEC Filing  
12/9/2015Joseph P. Pellegrino, Jr.CFOSell14,348$16.01$229,711.48View SEC Filing  
12/4/2015Peter R. GebauerinsiderSell12,816$15.53$199,032.48View SEC Filing  
12/1/2015Peter R. GebauerinsiderSell37,184$15.73$584,904.32View SEC Filing  
11/25/2015David B. RobertsDirectorSell10,000$15.96$159,600.00View SEC Filing  
11/24/2015Cornelia W LemaitreDirectorSell41,135$15.61$642,117.35View SEC Filing  
11/23/2015George W. LemaitreCEOSell65,052$15.63$1,016,762.76View SEC Filing  
11/23/2015Joseph P. Pellegrino, Jr.CFOSell45,840$15.57$713,728.80View SEC Filing  
11/23/2015Peter R. GebauerinsiderSell11,971$15.31$183,276.01View SEC Filing  
11/20/2015David B. RobertsDirectorSell10,000$14.73$147,300.00View SEC Filing  
11/20/2015Peter R. GebauerinsiderSell19,900$14.40$286,560.00View SEC Filing  
11/17/2015George W LemaitreCEOSell30,000$14.15$424,500.00View SEC Filing  
11/16/2015Lawrence J. JasinskiDirectorSell7,500$13.57$101,775.00View SEC Filing  
11/10/2015George W. LemaitreCEOSell57,844$13.80$798,247.20View SEC Filing  
11/9/2015George W. LemaitreCEOSell7,524$13.70$103,078.80View SEC Filing  
11/6/2015George W. LemaitreCEOSell39,000$13.83$539,370.00View SEC Filing  
10/30/2015George W. LemaitreCEOSell16,190$14.55$235,564.50View SEC Filing  
10/28/2015Peter R. GebauerinsiderSell44,315$13.97$619,080.55View SEC Filing  
9/25/2015Peter R. GebauerinsiderSell5,441$13.91$75,684.31View SEC Filing  
9/18/2015George W. LemaitreCEOSell46,391$14.37$666,638.67View SEC Filing  
9/17/2015George W. LemaitreCEOSell49,559$13.96$691,843.64View SEC Filing  
8/31/2015Peter R. GebauerinsiderSell10,465$13.49$141,172.85View SEC Filing  
8/27/2015George W. LemaitreCEOSell28,700$13.66$392,042.00View SEC Filing  
8/26/2015Peter R. GebauerinsiderSell15,978$13.53$216,182.34View SEC Filing  
8/20/2015David B RobertsDirectorSell12,000$13.58$162,960.00View SEC Filing  
8/19/2015Peter R. GebauerinsiderSell4,022$14.24$57,273.28View SEC Filing  
8/13/2015George W LemaitreCEOSell33,059$13.41$443,321.19View SEC Filing  
5/19/2015Peter R GebauerInsiderSell10,000$10.12$101,200.00View SEC Filing  
5/18/2015George W LemaitreCEOSell20,132$10.01$201,521.32View SEC Filing  
5/11/2015David B RobertsDirectorSell15,000$10.31$154,650.00View SEC Filing  
5/7/2015George W LemaitreCEOSell70,984$9.72$689,964.48View SEC Filing  
5/6/2015David B RobertsDirectorSell11,000$9.27$101,970.00View SEC Filing  
4/29/2015Peter R GebauerInsiderSell15,332$8.99$137,834.68View SEC Filing  
4/16/2015Cornelia W LemaitreDirectorSell17,100$8.55$146,205.00View SEC Filing  
4/14/2015Cornelia W LemaitreDirectorSell6,707$8.42$56,472.94View SEC Filing  
3/31/2015Cornelia W LemaitreDirectorSell819$8.37$6,855.03View SEC Filing  
3/30/2015Cornelia W LemaitreDirectorSell31$8.36$259.16View SEC Filing  
3/25/2015Cornelia W LemaitreDirectorSell3,678$8.33$30,637.74View SEC Filing  
3/24/2015Cornelia W LemaitreDirectorSell3,373$8.33$28,097.09View SEC Filing  
3/23/2015Cornelia W LemaitreDirectorSell26,026$8.21$213,673.46View SEC Filing  
3/18/2015Cornelia W LemaitreDirectorSell5,601$8.03$44,976.03View SEC Filing  
3/10/2015Peter R GebauerInsiderSell10,000$8.15$81,500.00View SEC Filing  
3/9/2015Peter R GebauerInsiderSell7,200$8.15$58,680.00View SEC Filing  
3/6/2015Cornelia W LemaitreDirectorSell6,065$8.20$49,733.00View SEC Filing  
3/3/2015David B RobertsDirectorSell12,000$7.65$91,800.00View SEC Filing  
1/29/2015Peter R GebauerInsiderSell16,919$7.91$133,829.29View SEC Filing  
1/26/2015George W LemaitreCEOSell3,486$7.85$27,365.10View SEC Filing  
1/26/2015Peter R GebauerInsiderSell1,800$7.90$14,220.00View SEC Filing  
1/5/2015George W LemaitreCEOSell18,447$7.74$142,779.78View SEC Filing  
1/2/2015David B RobertsDirectorSell7,000$7.31$51,170.00View SEC Filing  
12/30/2014George W LemaitreCEOSell18,067$7.58$136,947.86View SEC Filing  
12/29/2014George W LemaitreCEOSell5,058$7.59$38,390.22View SEC Filing  
12/26/2014George W LemaitreCEOSell6,693$7.53$50,398.29View SEC Filing  
12/24/2014George W LemaitreCEOSell2,900$7.60$22,040.00View SEC Filing  
12/10/2014George W LemaitreCEOSell1,117$7.40$8,265.80View SEC Filing  
12/9/2014David B RobertsDirectorSell3,000$7.36$22,080.00View SEC Filing  
12/9/2014George W LemaitreCEOSell1,794$7.40$13,275.60View SEC Filing  
11/28/2014George W LemaitreCEOSell42,641$7.40$315,543.40View SEC Filing  
11/25/2014George W LemaitreCEOSell613$7.30$4,474.90View SEC Filing  
11/13/2014Trent G KamkeInsiderSell1,100$7.15$7,865.00View SEC Filing  
11/5/2014George W LemaitreCEOSell28,286$7.07$199,982.02View SEC Filing  
10/31/2014David B RobertsPresidentSell3,500$7.03$24,605.00View SEC Filing  
10/31/2014George W LemaitreCEOSell23,758$7.14$169,632.12View SEC Filing  
9/8/2014George W LemaitreCEOSell29,966$7.10$212,758.60View SEC Filing  
9/4/2014Lawrence J JasinskiDirectorSell3,750$7.14$26,775.00View SEC Filing  
6/25/2014Cornelia W LemaitreDirectorSell4,700$8.32$39,104.00View SEC Filing  
5/7/2014David RobertsPresidentSell3,000$7.95$23,850.00View SEC Filing  
3/7/2014Russell HaysDirectorSell15,000$8.07$121,050.00View SEC Filing  
3/6/2014Cornelia LemaitreDirectorSell6,950$8.15$56,642.50View SEC Filing  
3/6/2014Trent KamkeInsiderSell1,278$8.18$10,454.04View SEC Filing  
3/4/2014Cornelia LemaitreDirectorSell12,845$8.29$106,485.05View SEC Filing  
1/23/2014Cornelia LemaitreDirectorSell3,900$8.24$32,136.00View SEC Filing  
11/1/2013David B RobertsDirectorSell2,000$7.96$15,920.00View SEC Filing  
10/31/2013Cornelia W LemaitreDirectorSell20,000$7.88$157,600.00View SEC Filing  
10/25/2013Cornelia W LemaitreDirectorSell20,000$7.38$147,600.00View SEC Filing  
9/5/2013Joseph P Pellegrino JrCFOSell25,000$6.86$171,500.00View SEC Filing  
9/3/2013David B RobertsDirectorSell6,500$6.90$44,850.00View SEC Filing  
8/14/2013Cornelia W LemaitreDirectorSell7,500$7.00$52,500.00View SEC Filing  
8/12/2013Trent G KamkeInsiderSell2,000$6.90$13,800.00View SEC Filing  
8/8/2013Trent G KamkeInsiderSell2,000$6.83$13,660.00View SEC Filing  
8/2/2013Russell D HaysDirectorSell15,000$6.78$101,700.00View SEC Filing  
7/30/2013David B RobertsDirectorSell12,403$6.85$84,960.55View SEC Filing  
7/29/2013Cornelia W LemaitreDirectorSell2,500$7.00$17,500.00View SEC Filing  
7/26/2013David B RobertsDirectorSell9,100$6.77$61,607.00View SEC Filing  
6/24/2013David B RobertsDirectorSell2,100$6.75$14,175.00View SEC Filing  
6/5/2013Robert V LindenVPSell9,383$6.45$60,520.35View SEC Filing  
5/30/2013Cornelia W LemaitreDirectorSell10,000$6.50$65,000.00View SEC Filing  
11/27/2012Cornelia W LemaitreDirectorSell2,699$6.25$16,868.75View SEC Filing  
8/10/2012George D LemaitreDirectorSell5,862$6.45$37,809.90View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for LeMaitre Vascular (NASDAQ:LMAT)
DateHeadline
stocksdaily.net logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Had $27.451 In Cash And ... - Stocks Daily (NASDAQ:LMAT)
www.stocksdaily.net - September 26 at 10:34 AM
finance.yahoo.com logoLemaitre Vascular downgraded by Sidoti (NASDAQ:LMAT)
finance.yahoo.com - September 22 at 5:43 PM
finance.yahoo.com logoLeMaitre Vascular to Participate in the Dougherty & Co. Institutional Investor Conference on September 28, 2016 - Yahoo Finance (NASDAQ:LMAT)
finance.yahoo.com - September 21 at 10:04 AM
publicnow.com logoLeMaitre Vascular to Participate in the Dougherty & Co. Institutional Investor Conference on September 28, 2016 (NASDAQ:LMAT)
www.publicnow.com - September 21 at 10:04 AM
finance.yahoo.com logoCan the Rally in LeMaitre Vascular (LMAT) Shares Continue? (NASDAQ:LMAT)
finance.yahoo.com - September 20 at 11:05 AM
finance.yahoo.com logoIs LeMaitre Vascular (LMAT) a Great Growth Stock? (NASDAQ:LMAT)
finance.yahoo.com - September 20 at 11:05 AM
stocksdaily.net logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Held $27.451 In Cash And Short-Term Investments - Stocks Daily (NASDAQ:LMAT)
www.stocksdaily.net - September 18 at 5:38 PM
capitalcube.com logoETF’s with exposure to LeMaitre Vascular, Inc. : September 14, 2016 (NASDAQ:LMAT)
www.capitalcube.com - September 14 at 6:01 PM
finance.yahoo.com logoLeMaitre Hits 52-Week High on Strong International Presence (NASDAQ:LMAT)
finance.yahoo.com - September 14 at 10:10 AM
stocksdaily.net logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) CFF Stands At $1.079 Millions - Stocks Daily (NASDAQ:LMAT)
www.stocksdaily.net - September 12 at 5:42 PM
finance.yahoo.com logo3 Reasons Why LeMaitre Vascular (LMAT) is a Great Momentum Stock (NASDAQ:LMAT)
finance.yahoo.com - September 12 at 10:38 AM
theglobeandmail.com logoThis medical equipment manufacturer may help revive your portfolio (NASDAQ:LMAT)
www.theglobeandmail.com - September 8 at 5:46 PM
News IconClosed Near the Highs for the Day (NASDAQ:LMAT)
www.fxstreet.com - September 7 at 9:29 AM
thestreet.com logoLMAT Crosses Above Average Analyst Target (NASDAQ:LMAT)
www.thestreet.com - September 7 at 9:29 AM
News IconCrowd Sentiment & Analyst Review on LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Post News (NASDAQ:LMAT)
www.kentuckypostnews.com - August 29 at 5:53 PM
stocksdaily.net logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Paying Out $-2.845 Million ... - Stocks Daily (NASDAQ:LMAT)
www.stocksdaily.net - August 29 at 10:32 AM
finance.yahoo.com logoLeMaitre Vascular to Attend the 9th Annual Barrington Research Fall Investment Conference on September 8, 2016 (NASDAQ:LMAT)
finance.yahoo.com - August 25 at 5:57 PM
investornewswire.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:LMAT)
www.investornewswire.com - August 24 at 5:49 PM
capitalcube.com logoETF’s with exposure to LeMaitre Vascular, Inc. : August 22, 2016 (NASDAQ:LMAT)
www.capitalcube.com - August 22 at 6:00 PM
investornewswire.com logoWill LeMaitre Vascular, Inc. (NASDAQ:LMAT) Hit $20 Price Target? - Investor Newswire (NASDAQ:LMAT)
www.investornewswire.com - August 18 at 8:59 AM
nasdaq.com logoMoving Average Crossover Alert: LeMaitre Vascular (LMAT) - Nasdaq (NASDAQ:LMAT)
www.nasdaq.com - August 18 at 8:59 AM
nasdaq.com logoLeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for ... - Nasdaq (NASDAQ:LMAT)
www.nasdaq.com - August 18 at 8:59 AM
nasdaq.com logoMoving Average Crossover Alert: LeMaitre Vascular (LMAT) (NASDAQ:LMAT)
www.nasdaq.com - August 16 at 6:04 PM
publicnow.com logoLeMaitre Vascular to Participate in the Midwest IDEAS Investor Conference on August 30, 2016 (NASDAQ:LMAT)
www.publicnow.com - August 16 at 6:04 PM
finance.yahoo.com logoWill LeMaitre Vascular (LMAT) Continue to Surge Higher? (NASDAQ:LMAT)
finance.yahoo.com - August 11 at 9:04 AM
capitalcube.com logoLeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:LMAT)
www.capitalcube.com - August 5 at 6:08 PM
biz.yahoo.com logoLEMAITRE VASCULAR INC Files SEC form 10-Q, Quarterly Report (NASDAQ:LMAT)
biz.yahoo.com - August 5 at 6:08 PM
finance.yahoo.com logoLeMaitre Vascular to Participate in the Canaccord Genuity 36th Annual Growth Conference on August 11, 2016 (NASDAQ:LMAT)
finance.yahoo.com - August 2 at 6:15 PM
finance.yahoo.com logoOmnicell (OMCL) Tops Q2 Earnings & Revenues, Margins Drag (NASDAQ:LMAT)
finance.yahoo.com - August 2 at 6:15 PM
finance.yahoo.com logoCVS Health (CVS) Tops Q2 Earnings, Lags on Revenue, View Up (NASDAQ:LMAT)
finance.yahoo.com - August 2 at 6:15 PM
finance.yahoo.com logoEdited Transcript of LMAT earnings conference call or presentation 27-Jul-16 9:00pm GMT (NASDAQ:LMAT)
finance.yahoo.com - August 1 at 5:48 PM
capitalcube.com logoLeMaitre Vascular, Inc.: Leads amongst peers with strong fundamentals (NASDAQ:LMAT)
www.capitalcube.com - July 29 at 4:29 PM
4-traders.com logoLeMaitre Vascular : beats Street 2Q forecasts (NASDAQ:LMAT)
www.4-traders.com - July 28 at 9:07 AM
sg.finance.yahoo.com logoLeMaitre beats Street 2Q forecasts (NASDAQ:LMAT)
sg.finance.yahoo.com - July 27 at 7:10 PM
investornewswire.com logoCan Shares Of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Hit $18.5? - Investor Newswire (NASDAQ:LMAT)
www.investornewswire.com - July 27 at 6:17 PM
finance.yahoo.com logo5:06 pm Lemaitre Vascular beats by $0.03, beats on revs; guides Q3 above consensus, raises 2016 guidance, announces $5 mln buyback (NASDAQ:LMAT)
finance.yahoo.com - July 27 at 5:06 PM
publicnow.com logoLeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) (NASDAQ:LMAT)
www.publicnow.com - July 27 at 4:28 PM
biz.yahoo.com logoLEMAITRE VASCULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Stat (NASDAQ:LMAT)
biz.yahoo.com - July 27 at 4:15 PM
tradecalls.org logoPerkins Capital Management Inc Lowers stake in LeMaitre Vascular Inc (LMAT) - Trade Calls (NASDAQ:LMAT)
www.tradecalls.org - July 27 at 8:54 AM
biz.yahoo.com logoQ2 2016 LeMaitre Vascular Inc Earnings Release - After Market Close (NASDAQ:LMAT)
biz.yahoo.com - July 27 at 7:07 AM
stocksdaily.net logoCash And Short-Term Investments For LeMaitre Vascular, Inc. (NASDAQ:LMAT) Was $27.451 - Stocks Daily (NASDAQ:LMAT)
www.stocksdaily.net - July 26 at 8:59 AM
News IconHow Analysts Feel About LeMaitre Vascular Inc (NASDAQ:LMAT ... - Consumer Eagle (NASDAQ:LMAT)
www.consumereagle.com - July 21 at 6:08 PM
News IconLeMaitre Vascular, Inc. (NASDAQ:LMAT): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:LMAT)
www.engelwooddaily.com - July 20 at 4:06 PM
News IconLeMaitre Vascular, Inc. (NASDAQ:LMAT) Wall Street Analyst Recommendation Outlook - TGP (NASDAQ:LMAT)
telanaganapress.com - July 19 at 6:03 PM
News IconShares Lower on the Year LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Press Telegraph (NASDAQ:LMAT)
presstelegraph.com - July 19 at 6:03 PM
finance.yahoo.com logoLeMaitre Vascular Will Announce Second Quarter 2016 Earnings Results on July 27, 2016 (NASDAQ:LMAT)
finance.yahoo.com - July 19 at 3:37 PM
fiscalstandard.com logoLeMaitre Vascular, Inc. (LMAT) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:LMAT)
www.fiscalstandard.com - July 17 at 10:17 AM
News IconLemaitre Vascular Incorporated (NASDAQ:LMAT) Shorts Decreased by 12.05% After Short Covering - Consumer Eagle (NASDAQ:LMAT)
www.consumereagle.com - July 15 at 10:09 AM
News IconAre Analysts Bearish LeMaitre Vascular Inc (NASDAQ:LMAT) After Last Week? - Consumer Eagle (NASDAQ:LMAT)
www.consumereagle.com - July 14 at 6:09 PM
investornewswire.com logoStrong Sell Calls For LeMaitre Vascular, Inc. (NASDAQ:LMAT) At 0 - Investor Newswire (NASDAQ:LMAT)
www.investornewswire.com - July 14 at 6:09 PM

Social

LeMaitre Vascular (NASDAQ:LMAT) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff